Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

CSD210903: A Study to Determine Subject Puffing Patterns of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in an Ambulatory Setting

NCT05307822 · View on ClinicalTrials.gov ↗

Study Summary

This is a multi-center, open-label, parallel-cohort-study to evaluate the puffing patterns of healthy adult consumers of tobacco products switching from a usual brand (UB) combustible cigarette (CC) and/or a UB Heated Tobacco Product (HTP) to one of four investigational products (IPs), across two heating modes, over a 28-day ambulatory period.

Interventions

  • OTHER Non-combusted cigarette variant 42001401
  • OTHER Non-combusted cigarette variant 42001399
  • OTHER Non-combusted cigarette variant 40007386
  • OTHER Non-combusted cigarette variant 42001402

Study Locations (7)

North Carolina

  • Rose Research Center — Charlotte
  • High Point Clinical Trials Center — High Point
  • Rose Research Center — Raleigh

Texas

  • Benchmark Research — Fort Worth
  • Benchmark Research — San Angelo

Georgia

  • Wake Research (MTVCR) — Sandy Springs

Kentucky

  • AMR Lexington — Lexington

Trial Details

FieldValue
Enrollment Target 194 participants
Start Date 2022-04-21
Est. Completion 2022-11-11
Phase NA

Sponsor

RAI Services Company

10 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05307822

The ClinicalTrials.gov registry entry for NCT05307822 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAI Services Company, which has 10 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 4 conditions, with Smoking appearing as the primary indexed condition, and to 4 interventions — of which Non-combusted cigarette variant 42001401 is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT05307822 reports 7 study locations spanning 4 distinct geographic areas — top geographies include North Carolina, Texas, Georgia. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT05307822 about?

NCT05307822 is a clinical study titled "CSD210903: A Study to Determine Subject Puffing Patterns of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in an Ambulatory Setting". This is a multi-center, open-label, parallel-cohort-study to evaluate the puffing patterns of healthy adult consumers of tobacco products switching from a usual brand (UB) combustible cigarette (CC) and/or a UB Heated Tobacco Product (HTP) to one of four investigational products (IPs), across two he...

What is the current status of trial NCT05307822?

This trial is currently completed. It is a NA study. The enrollment target is 194 participants. The study started on 2022-04-21. Estimated completion is 2022-11-11.

What conditions does trial NCT05307822 study?

This clinical trial studies the following conditions: Smoking, Tobacco Use, Tobacco Smoking, Smoking Behaviors. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT05307822?

The interventions under investigation include: Non-combusted cigarette variant 42001401 (OTHER), Non-combusted cigarette variant 42001399 (OTHER), Non-combusted cigarette variant 40007386 (OTHER), Non-combusted cigarette variant 42001402 (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT05307822?

This trial is sponsored by RAI Services Company, which has 10 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT05307822 being conducted?

This trial has 7 study locations across Georgia, Kentucky, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial